Thus, we speculated ZC3H13, IGF2BP3, and DDX19B might participate in the occurrence and development of HCC through regulating their correlated AS events and inducing dysregulation of above cancer-related pathways. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.